This article was originally published on TipRanks.com GlaxoSmithKline (GSK) has turned down three unsolicited and non-binding takeover proposals for its Consumer Healthcare business …
This article was originally published on TipRanks.com Ligand Pharmaceuticals’ (LGND) subsidiary Icagen and GlaxoSmithKline (GSK) have announced plans to expand their collaboration and license …
This article was originally published on TipRanks.com GlaxoSmithKline (GSK) and Vir Biotechnology, Inc.
Alector Inc. (ALEC), a clinical stage biotechnology company, has been in the headlines recently.
The global pharmaceutical company GlaxoSmithKline plc (GSK) announced the strategic separation of its Consumer Healthcare business, to be completed by mid-2022. The New …
Biopharmaceutical company Halozyme Therapeutics (HALO) has entered into a global collaboration and licensing agreement with ViiV Healthcare to further the development of ultra-long-acting …
GlaxoSmithKline (GSK) and Vir Biotechnology’s (VIR) investigational single-dose monoclonal antibody sotrovimab (previously named VIR-7831) has been authorized for emergency use by the U.S.
Sanofi’s CEO, Paul Hudson, said that the mRNA-based (messenger Ribonucleic acid) COVID-19 vaccine developed by the pharma giant and Translate Bio will not …
Sanofi (SNYNF) and GlaxoSmithKline (GSK) intend to make available 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine, if approved by regulatory …
Sanofi (SNYNF) and and GlaxoSmithKline (GSK) are in advanced discussions with the European Commission (EC) for the supply of up to 300 million …
